Biocon Pharma Secures US FDA Nod for Sacubitril/Valsartan Tablets
Sept. 1, 2024, 3:39 p.m.
Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval from the U.S. Food and Drug Administration (US FDA) for its ANDA (Abbreviated New Drug Application) f…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.